Overview
Updated 14 Jul 2026
John H. Krystal, MD, is Robert L. McNeil, Jr. Professor of Translational Research at Yale University / Yale School of Medicine, Department of Psychiatry. The public record shows 1,034 publications with 89,336 citations (h-index 158), centered on Bipolar Disorder, Schizophrenia, Depression (MDD). It also documents an investigator role on 10 registered clinical trials, industry payments reported by 13 companies, 24 NIH-funded awards (1995–2026).
- Most recent indexed publication: 2026 · Molecular psychiatry
- Top research focus: Bipolar Disorder
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Written testimony to the Connecticut General Assembly (Appropriations Committee) supporting HB-5048
An Act Adjusting the State Budget, as Chair, Department of Psychiatry, Yale University
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cga.ct.gov ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
InvestigatorPhase 1RecruitingNCT06335407 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Sponsor: Yale University
InvestigatorPhase 1RecruitingNCT05915013 - A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
Sponsor: Yale University
InvestigatorPhase 2CompletedNCT04457310
Industry payments
Updated 14 Jul 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year202514 payments$13,058openpaymentsdata.cms.gov ↗
- Alkermes, Inc.Program year20251 payment$10,605openpaymentsdata.cms.gov ↗
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
NIH funding
Updated 14 Jul 2026
24 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- Yale Clinical and Translational Science Award (U Component)
Yale University
FY2026$4,812,525UL1TR001863 - AMPA Receptor Components of the Antidepressant Response to Ketamine in Humans
Yale University
FY2026$834,244R01MH129371
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
333 Cedar Street, New Haven, CT 06510
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- Board Certified in Psychiatry
American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Editorial & leadership rolesjournal and society appointments
- Co-Director
Yale Center for Clinical Investigation (CTSA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Director
NIAAA Center for the Translational Neuroscience of Alcohol (CTNA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Director
Clinical Neuroscience Division, VA National Center for PTSD, VA Connecticut
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Awards & honorshonors on the public record
- 2026 Connecticut Medal of Technology (Connecticut Academy of Science and Engineering)
for the discovery of the rapid antidepressant actions of ketamine
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychology.yale.edu ↗
- Co-founder
Freedom Biosciences (rapid-acting antidepressant therapeutics)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Scientific Advisory Board member
Aligning Research to Impact Autism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Media & interviewspress, podcasts and appearances
- Brave New World podcast (Evgeny Lebedev / The Standard/Acast)
"Why ketamine can solve a mental health epidemic"
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →shows.acast.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tim.blog ↗
- Psychiatric Times interview
"Exploring the Future of Ketamine and Psychedelic Treatment"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/john-krystal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
freedombio.co/team/dr-john-krystal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →freedombio.co ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harlan Krumholz, MD
Yale University
- 2,898
- publications
- 216
- h-index
- 15
- trials
Lajos Pusztai, MD
Yale University
- 1,394
- publications
- 114
- h-index
- 13
- trials
Kevin Sheth, MD
Yale University
- 821
- publications
- 78
- h-index
- 5
- trials
William Tamborlane, MD
Yale University
- 571
- publications
- 107
- h-index
- 16
- trials